GABAergic disinhibition

"GABAergic disinhibition" is **not a specific molecule, protein, or receptor**, but rather describes a **neural circuit phenomenon** in which the inhibition exerted by GABAergic interneurons is itself inhibited—typically by other inhibitory neurons—resulting in an overall increase in the activity of downstream excitatory neurons. This process often involves specialized interneuron subtypes such as vasoactive intestinal peptide (VIP)-expressing cells that preferentially inhibit other inhibitory neurons like somatostatin-positive or parvalbumin-positive interneurons. The net effect is to "disinhibit" principal cells such as pyramidal neurons, thereby modulating information flow and network excitability within brain circuits[3]. GABAergic disinhibition plays critical roles in various brain functions including rapid switching between behavioral states, gating sensory input, controlling motor programs, and shaping cognitive processes like working memory through modulation of gamma-band oscillations[2][5]. Dysregulation of this balance between inhibition and disinhibition has been implicated in neuropsychiatric and neurological disorders. Because "GABAergic disinhibition" refers to a **functional circuit motif** rather than an individual molecular target (such as a receptor or enzyme), it does not have canonical names/abbreviations nor direct interacting drugs. Instead, drugs that modulate components involved—such as GABA-A/B/C receptors or specific classes of interneurons—can indirectly influence this process. In summary: **GABAergic disinhibition is not itself a therapeutic target but describes how certain neural circuits regulate excitation via layered inhibition; thus it should not be listed as a molecular drug target.**

Other names

GABAergic disinhibitionDisinhibitory GABAergic circuitVIP-expressing neuron disinhibition motif